Meta Shares Dip Amid Exec Sales and Skeptical Analysts

• Meta shares declined approximately 1% to $640 in early Monday trading, wiping out previous session gains
• CPO Christopher Cox offloaded 20,000 shares valued at roughly $13 million on September 9
• Additional executive sales by COO Javier Olivan and CAO Aaron Anderson added millions in transactions
• Wedbush and Oppenheimer analysts expressed skepticism regarding Muse Agent’s revenue-generating capabilities
• Despite concerns, Wall Street maintains a Strong Buy rating with an average target of $759.43, suggesting approximately 17% potential gains

Meta Platforms shares retreated nearly 1% to approximately $640 during Monday’s pre-market session, eliminating the modest 0.57% advance recorded in the previous trading day.

The decline came after securities filings revealed that Christopher Cox, the company’s Chief Product Officer, divested 20,000 shares on September 9 for an aggregate value of approximately $13 million. These transactions occurred under a Rule 10b5-1 trading arrangement that Cox established in May 2026.

The executive disposed of 18,578 shares at a weighted average price of $650.21, with an additional 1,422 shares sold at $651.15. Following these transactions, Cox maintains ownership of 244,516 shares held in a revocable trust alongside 55,046 shares in an irrevocable remainder trust.

The CPO wasn’t the only executive trimming positions. Chief Operating Officer Javier Olivan liquidated 5,354 shares for approximately $3.3 million, while Chief Accounting Officer Aaron Anderson sold 3,240 shares valued at roughly $2 million. Each of these sales was executed through pre-established trading plans.

Notwithstanding the cluster of executive sales, TipRanks’ Insider Trading Activity tool registers a Neutral sentiment for Meta based on current insider transactions. Company insiders have simultaneously purchased approximately $2.3 million in stock during the trailing three-month period.

The stock encountered additional headwinds as two Wall Street analysts refrained from upgrading their positions despite the introduction of Meta’s AI agent, Muse.

Wedbush analyst Ygal Arounian sustained a Hold rating on META on September 11, though he elevated his price objective 9% from $595 to $650. This revised target suggests minimal upside of just 0.30% from present trading levels.

Arounian recognized Muse as a notable advancement in Meta’s artificial intelligence initiatives but cautioned that the financial returns remain uncertain. He holds the #2,929 position among 12,499 analysts monitored on TipRanks.

Oppenheimer analyst Jason Helfstein assigned a Buy rating without establishing a price target, expressing uncertainty about Muse’s capacity to generate meaningful revenue for Meta.

Helfstein highlighted three particular challenges: insufficient consumer appetite to pay for the offering, intense rivalry from Google’s Gemini and OpenAI’s ChatGPT platforms, and consumer reluctance to entrust Meta with sensitive password information.

His assessment concluded that Muse Agent doesn’t represent “a game changer” for Meta’s business.

However, not every analyst shares this reserved outlook. Evercore ISI reaffirmed its Outperform designation with an $860 price objective. JPMorgan elevated META from Neutral to Overweight while boosting its target to $820, highlighting AI advancements and products including Muse and Meta Model API access. KeyBanc maintained its Overweight rating with a $780 projection.

The company also unveiled Muse Spark 1.3, which CEO Mark Zuckerberg characterized as representing the firm’s most substantial advancement in coding and agentic functionality to date.

Throughout Wall Street, META commands a Strong Buy consensus derived from 38 Buy recommendations and 6 Hold ratings issued during the past three months. The consensus price target stands at $759.43, indicating potential upside of approximately 17% from current trading levels.